Interview: Researchers Deconstruct Ghostwritten SSRI Trial

Researchers take a closer look at a trial of citalopram (Celexa) that was ghostwritten and then used to get FDA approval with children.

Related Keywords

Australia ,California ,United States ,University Of California San Francisco ,United Kingdom ,Amsterdam ,Noord Holland ,Netherlands ,Jon Jureidini ,Smith Kline ,Los Angeles ,Merck Vioxx ,Leemon Mchenry ,Aristei Goldman ,California State University ,International Journal Of Risk Safety In Medicine ,Jay Amsterdam ,Forest Labs ,International Journal ,Glaxo Smith Kline ,California San Francisco ,Drug Industry Document Archive ,Evidence Based Medicine ,Academic Integrity ,Adolescent Depression ,Ristei Amp Goldman ,Aum ,Celexa ,Child And Adolescent Depression ,Italopram Study Cit18 ,Onflict Of Interest And Medical Journals ,Scitalopram Lexapro ,Ghostwriting ,Hostwritten ,Laxo Smith Kline Gsk ,Sks Avandia ,Hedlund ,Igh Impact Medical Journals ,Nternational Journal Of Risk Amp Safety In Medicine ,Ay Amsterdam And Leemon Mchenry ,Key Opinion Leaders ,Eemon Mchenry Interview ,Marketing In Medicine ,Edical Communication Companies ,Edical Ghostwriters ,Medical Research News ,Ercks Vioxx ,Isrepresentation Through Ghostwriting ,Ff Label Promotion Of Celexa ,Aroxetine Paxil ,Pharmaceutical Companies ,Harmaceutical Research News ,Sychiatry Research News ,Andomized Control Trial Of Citalopram ,Scientific Honesty ,Tudy 329 ,Transparency ,Vioxx ,